D. E. Shaw & Co., Inc. Vanda Pharmaceuticals Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,802,842 shares of VNDA stock, worth $9.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,802,842
Previous 2,112,125
14.64%
Holding current value
$9.21 Million
Previous $8.91 Million
16.87%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding VNDA
# of Institutions
147Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$41.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$21.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$17.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$12.1 Million0.03% of portfolio
-
Tang Capital Management LLC San Diego, CA1.75MShares$8.95 Million0.88% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $289M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...